151 related articles for article (PubMed ID: 32732154)
1. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of an Omega-3 Fatty Acid Supplement in Patients With Predialysis Chronic Kidney Disease.
Bunout D; Barrera G; Hirsch S; Lorca E
J Ren Nutr; 2021 Jan; 31(1):64-72. PubMed ID: 32732154
[TBL] [Abstract][Full Text] [Related]
2. The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial.
Mori TA; Burke V; Puddey I; Irish A; Cowpland CA; Beilin L; Dogra G; Watts GF
J Hypertens; 2009 Sep; 27(9):1863-72. PubMed ID: 19705518
[TBL] [Abstract][Full Text] [Related]
3. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
de Borst MH; Baia LC; Hoogeveen EK; Giltay EJ; Navis G; Bakker SJL; Geleijnse JM; Kromhout D; Soedamah-Muthu SS
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137111
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 Fatty Acid Could Increase One of Myokines in Male Patients with Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
Agh F; Mohammadzadeh Honarvar N; Djalali M; Nematipour E; Gholamhoseini S; Zarei M; Ansari S; Javanbakht MH
Arch Iran Med; 2017 Jan; 20(1):28-33. PubMed ID: 28112528
[TBL] [Abstract][Full Text] [Related]
6. Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial.
Hoogeveen EK; Geleijnse JM; Kromhout D; Stijnen T; Gemen EF; Kusters R; Giltay EJ
Clin J Am Soc Nephrol; 2014 Oct; 9(10):1676-83. PubMed ID: 25104273
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics.
de Boer IH; Zelnick LR; Lin J; Schaumberg D; Wang L; Ruzinski J; Friedenberg G; Duszlak J; Bubes VY; Hoofnagle AN; Thadhani R; Glynn RJ; Buring JE; Sesso HD; Manson JE
Contemp Clin Trials; 2018 Nov; 74():11-17. PubMed ID: 30282055
[TBL] [Abstract][Full Text] [Related]
8. The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: results of the GO-FISH trial.
Miller ER; Juraschek SP; Anderson CA; Guallar E; Henoch-Ryugo K; Charleston J; Turban S; Bennett MR; Appel LJ
Diabetes Care; 2013 Jun; 36(6):1462-9. PubMed ID: 23275364
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H; Stackhouse C
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
[TBL] [Abstract][Full Text] [Related]
10. Oral supplementation with omega-3 fatty acids and inflammation markers in patients with chronic kidney disease in hemodialysis.
Valle Flores JA; Fariño Cortéz JE; Mayner Tresol GA; Perozo Romero J; Blasco Carlos M; Nestares T
Appl Physiol Nutr Metab; 2020 Aug; 45(8):805-811. PubMed ID: 31935118
[TBL] [Abstract][Full Text] [Related]
11. Effect of the omega-3 fatty acid plus vitamin E supplementation on subjective global assessment score, glucose metabolism, and lipid concentrations in chronic hemodialysis patients.
Asemi Z; Soleimani A; Bahmani F; Shakeri H; Mazroii N; Abedi F; Fallah M; Mohammadi AA; Esmaillzadeh A
Mol Nutr Food Res; 2016 Feb; 60(2):390-8. PubMed ID: 26518514
[TBL] [Abstract][Full Text] [Related]
12. Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebo-controlled study.
Bennett WM; Carpenter CB; Shapiro ME; Strom TB; Hefty D; Tillman M; Abrams J; Ryan D; Kelley VR
Transplantation; 1995 Feb; 59(3):352-6. PubMed ID: 7871564
[TBL] [Abstract][Full Text] [Related]
13. Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial.
Rodríguez-Cruz M; Cruz-Guzmán ODR; Almeida-Becerril T; Solís-Serna AD; Atilano-Miguel S; Sánchez-González JR; Barbosa-Cortés L; Ruíz-Cruz ED; Huicochea JC; Cárdenas-Conejo A; Escobar-Cedillo RE; Yam-Ontiveros CA; Ricárdez-Marcial EF
Clin Nutr; 2018 Dec; 37(6 Pt A):1840-1851. PubMed ID: 28987470
[TBL] [Abstract][Full Text] [Related]
14. Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.
Soleimani A; Taghizadeh M; Bahmani F; Badroj N; Asemi Z
Clin Nutr; 2017 Feb; 36(1):79-84. PubMed ID: 26611718
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients.
Malekshahi Moghadam A; Saedisomeolia A; Djalali M; Djazayery A; Pooya S; Sojoudi F
Singapore Med J; 2012 Sep; 53(9):615-9. PubMed ID: 23023905
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Kwak SM; Myung SK; Lee YJ; Seo HG;
Arch Intern Med; 2012 May; 172(9):686-94. PubMed ID: 22493407
[TBL] [Abstract][Full Text] [Related]
17. Effects of omega-3 fatty acids on serum lipids, lipoprotein (a), and hematologic factors in hemodialysis patients.
Kooshki A; Taleban FA; Tabibi H; Hedayati M
Ren Fail; 2011; 33(9):892-8. PubMed ID: 21859401
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
[TBL] [Abstract][Full Text] [Related]
19. Effects of omega-3 polyunsaturated fatty acid supplementation in patients with chronic chagasic cardiomyopathy: study protocol for a randomized controlled trial.
Silva PS; Sperandio da Silva GM; de Souza AP; Cardoso CS; Fonseca CA; Brito PD; Saraiva RM; Brasil PE; Pinheiro RO; Hasslocher-Moreno AM; Xavier SS; Sousa AS
Trials; 2013 Nov; 14():379. PubMed ID: 24216069
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 fatty acids supplementation improves early-stage diabetic nephropathy and subclinical atherosclerosis in pediatric patients with type 1 diabetes: A randomized controlled trial.
Elbarbary NS; Ismail EAR; Mohamed SA
Clin Nutr; 2023 Dec; 42(12):2372-2380. PubMed ID: 37862823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
